Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAMYT.L Regulatory News (AMYT)

  • There is currently no data for AMYT

Operational Update

7 Jul 2014 07:00

RNS Number : 5184L
Fastnet Oil & Gas PLC
07 July 2014
 



7 July 2014

Fastnet Oil & Gas plc

("Fastnet" or the "Company")

 

FASTNET IMPROVES TERMS OF AND EXTENDS EXCLUSIVE OPTION AGREEMENT TO FARM INTO THE TENDRARA LAKBIR PETROLEUM AGREEMENT ONSHORE MOROCCO AND PROVIDES OPERATIONAL UPDATE

 

Fastnet (AIM: FAST, ESM: FOI), the UK and Irish listed E&P company focussed on near term exploration and appraisal acreage in Morocco and the Celtic Sea, is pleased to announce that its wholly owned subsidiary Pathfinder Hydrocarbon Ventures Limited ("Pathfinder") has entered into an amended exclusive option agreement with Oil and Gas Investments Funds ("OGIF") (the "Option Agreement"), in relation to eight Exploration Permits comprising the Tendrara Lakbir Petroleum Agreement (the "Tendrara Licence") onshore Morocco.

Following substantive negotiations with its partner OGIF, Fastnet has secured improved commercial terms from those previously announced on 29 May 2013. These include:

· Extension of the Option Agreement to 31 December 2014

· Fastnet's net equity interest increased from 37.5% to 50% upon the option being exercised and subject to the necessary Moroccan Government approvals

· Fastnet will carry OGIF in the first well required during the Initial Period of the Tendrara Licence

· At Fastnet's election, Fastnet will carry OGIF for a well on the TE-5 Structure, or an exploration well on any alternative gas prospect and/or existing gas discovery in the Tendrara Licence Area as required by the committed work programme of the First Extension Period 

· This reduces the drilling commitments under the original Option Agreement, which involved carrying OGIF in three wells; the first well plus two additional appraisal/exploration wells by 1 April 2015 and 1 April 2018, respectively

· The deadline to drill the first well has been extended from 30 September 2014 to 21 April 2015. The time in between exercising the Option Agreement and the drilling deadline allows Fastnet to acquire its net equity interest in the Tendrara Licence and Association Contract prior to commencing the drilling programme as the designated operator 

· Fastnet will be required to provide OGIF with an executed drilling contract or alternatively an irrevocable bank guarantee of USD$2.75 million 

Operational Update

In addition the revised commercial terms under the Option Agreement described above, Fastnet is also pleased to provide the following operational update in relation to the Tendrara Licence:

· Reservoir engineering studies have been completed and currently the new Pre-Stack Seismic Depth Migrations are being interpreted to select final drilling locations and to finalise well design

 

· Well planning, rig selection and environmental impact studies are ongoing and will be completed during this calendar year

 

· In order to accelerate monetisation of the TE-5 gas asset, Fastnet is seeking an additional drilling partner, with onshore gas development experience, to facilitate executing a drilling programme that will target materially higher potential gross gas resources; the gross unrisked High Estimate gas resources for the TE-5 Structure are 891.9 BCF. The Best Estimate gas resources, targeted by the original proposed drilling programme, are 310.5 BCF

 

· Discussions with suitably qualified potential partners, who have all expressed an interest in participating in a potential gas development, are underway and are expected to conclude in H2 2014

Paul Griffiths, Managing Director of Fastnet, commented:

"The revised terms significantly reduce Fastnet's financial exposure and provide us with much improved project economics. The process of bringing in an additional partner is underway. We expect that the new commercial terms and project economics should allow us to attract a major partner, with experience in developing and monetising onshore gas discoveries, by offering sufficient equity, whilst maintaining a material equity level for Fastnet shareholders as we seek to target materially higher potential gas resources in the planned drilling programme. We maintain our strategy of prudently managing our cash resources as we did through our successful Foum Assaka farm-out, which de-risked our financial exposure to the drilling costs. We believe that the Tendrara Licence is highly attractive to a potential strategic gas partner given the existing TE-5 gas discovery with near term development potential, and the additional prospectivity of multiple play types within the large licence area which provides significant potential upside."

For further information, please contact:

Fastnet Oil & Gas plc

Cathal Friel, Chairman

Paul Griffiths, Managing Director

+353 (1) 644 0007

Shore Capital

Nomad

Bidhi Bhoma, Edward Mansfield

Corporate Broking

Jerry Keen

+44 (0) 20 7408 4090

 

GMP Securities Europe LLP

(Joint Broker)

Rob Collins, Emily Morris, Liz Williamson

 

+44 (20) 20 7467 2800

Davy

(ESM Adviser & Joint Broker)

John Frain

Anthony Farrell

 

 +353 (1) 679 6363

Bell Pottinger

Philip Dennis, Rollo Crichton-Stuart, Jimmy Lea

 

 +44 (0) 207 861 3232

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFZLFBZDFEBBV
Date   Source Headline
24th Apr 20177:00 amRNSFirst Patient Enrolled
10th Apr 20175:21 pmRNSDirector/PDMR Shareholding
6th Apr 20174:13 pmRNSPosting of Annual Report 2016 and Notice of AGM
30th Mar 20177:00 amRNSFinal Results
28th Mar 20177:00 amRNSPhase 3 Clinical Trial for AP101 commenced
27th Mar 20177:00 amRNSSenior Management Appointment
8th Mar 20177:00 amRNSNotice of Results
6th Mar 20177:00 amRNSAP101 trial discussions completed with FDA & EMA
9th Feb 20177:00 amRNSDirectorate Change
7th Feb 20177:00 amRNSGrant of patent in Japan for AP101 (Episalvan)
6th Feb 20177:00 amRNSPre-clinical study results
5th Dec 20167:00 amRNSTransformational Licence Agreement
2nd Dec 20167:00 amRNSEUR20m Facility with European Investment Bank
7th Nov 20167:00 amRNSOrphan drug designation for Acromegaly Compound
19th Sep 20167:00 amRNSAppointment of Chief Medical Officer
13th Sep 20167:00 amRNSGrant of US patent for lead drug, Episalvan
13th Sep 20167:00 amRNSHalf-year Report
7th Jul 201612:54 pmRNSResult of AGM
27th Jun 20167:00 amRNSMarkus Ziener appointed as Non-Executive Director
9th Jun 20167:00 amRNSFinancial Results
2nd Jun 20164:34 pmRNSNotice of Results
21st Apr 20164:35 pmRNSHolding(s) in Company
19th Apr 20167:00 amRNSAdmission to trading on AIM and ESM
18th Apr 20162:30 pmRNSSchedule One update - Fastnet Equity plc
18th Apr 20162:30 pmRNSESM Schedule 1 Update
18th Apr 201612:41 pmRNSResult of General Meeting and Change of Name
31st Mar 20167:35 amRNSESM Schedule 1
31st Mar 20167:30 amRNSSchedule One - Fastnet Equity plc
31st Mar 20167:30 amRNSRestoration - Fastnet Equity plc
31st Mar 20167:00 amRNSProposed Acquisition of Amryt Pharmaceuticals
22nd Feb 20167:30 amRNSSuspension - Fastnet Equity plc
22nd Feb 20167:30 amRNSPotential Acquisition and Statement re Suspension
21st Dec 20157:01 amRNSAppointment of Non-executive Director
21st Dec 20157:00 amRNSInterim Results
18th Dec 20157:00 amRNSDemerger of Oil and Gas Assets
30th Sep 20153:12 pmRNSResult of Annual General Meeting
4th Sep 20157:00 amRNSFinal Results
28th Aug 20153:31 pmRNSResult of General Meeting
11th Aug 20153:35 pmRNSProposed adoption of Investing Policy/Notice of GM
3rd Jul 20153:22 pmRNSDirector/PDMR Shareholding
26th Jun 20152:45 pmRNSDirector/PDMR Shareholding
2nd Jun 20152:27 pmRNSHolding(s) in Company
1st Jun 20157:00 amRNSCorporate Update
26th Mar 20157:00 amRNSCeltic Sea Portfolio
27th Jan 201512:56 pmRNSDirectorate Change
9th Jan 201512:49 pmRNSHolding(s) in Company
2nd Jan 20157:00 amRNSExpiry of Tendrara Option Agreement
19th Dec 20147:00 amRNSInterim Results
10th Dec 20147:00 amRNSBoard changes & operational update
1st Dec 20143:00 pmRNSResponse to press speculation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.